Brief: Inhalation Sciences Sweden Divests Holding In Ziccum Securing Long-Term Financing
April 23 (Reuters) - Inhalation Sciences Sweden AB
ISAB.TE :
* DIVESTS HOLDING IN ZICCUM SECURING LONG-TERM FINANCING
* TOTAL DIVESTMENT VALUE ABOUT SEK 21.2 MILLION AFTER SALES
COSTS
* SALE ENTAILS ACCOUNTING PROFIT OF ABOUT SEK 19.5 MILLION
Source text for Eikon: ID:nWkrb8MjqG
Further company coverage: ISAB.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Inhalation Sciences Sweden AB
See all newsBrief: Inhalation Sciences Gets Order Of EUR 60,000 From Long-Term Big Pharma Client
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna